Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Expert Opinion on Pharmacotherapy|October 6, 2004
A cost-benefit analysis of chemotherapy for gastric cancerEva Galizia, Rossana Berardi, Mario Scartozzi, et al.
I Supplementi Di Tumori : Official Journal of Societa Italiana Di Cancerologia ... [Et Al.]|August 14, 2003
Adjuvant chemotherapy in gastric cancer. The Italian experience and review of the literatureRossana Berardi, Mario Scartozzi, Eva Galizia, et al.
Tumori|July 27, 2011
Second-line chemotherapy with irinotecan, 5-fluorouracil and leucovorin (FOLFIRI) in relapsed or metastatic gastric cancer: lessons from clinical practiceMirco Pistelli, Mario Scartozzi, Alessandro Bittoni, et al.
Cancer Treatment Reviews|July 13, 2004
Molecular biology of sporadic gastric cancer: prognostic indicators and novel therapeutic approachesMario Scartozzi, Eva Galizia, Federica Freddari, et al.
The Journal of Molecular Diagnostics : JMD|March 28, 2009
CAT25 is a mononucleotide marker to identify HNPCC patientsFrancesca Bianchi, Eva Galizia, Romina Catalani, et al.
Expert Opinion on Pharmacotherapy|April 12, 2007
Chemotherapy for advanced gastric cancer: across the years for a standard of careMario Scartozzi, Eva Galizia, Lorena Verdecchia, et al.
Future Oncology (London, England)|August 4, 2015
Retinal metastasis regression with eribulin in a heavily pretreated breast cancer patientMarta Gubbiotti, Barbara Pistilli, Marianna Tudini, et al.
Human Mutation|September 11, 2008
MSH2 missense mutations and HNPCC syndrome: pathogenicity assessment in a human expression systemLaura Belvederesi, Francesca Bianchi, Eva Galizia, et al.
Cancer Treatment Reviews|May 27, 2009
Toward molecularly selected chemotherapy for advanced gastric cancer: state of the art and future perspectivesMario Scartozzi, Alessandro Bittoni, Mirco Pistelli, et al.
Lung Cancer (Amsterdam, Netherlands)|August 12, 2009
Clinical predictive factors for advanced non-small cell lung cancer (NSCLC) patients receiving third-line therapy: Selecting the unselectable?Mario Scartozzi, Paola Mazzanti, Riccardo Giampieri, et al.
Pageof 3